Iridex (IRIX) Non Operating Interest Expenses (2012 - 2013)
Iridex (IRIX) posted Non Operating Interest Expenses of $171000.0 for Q4 2013, up 101.18% on a QoQ basis from $85000.0 in Q3 2013, and up 850.0% year-over-year from $18000.0 in Q4 2012.
Powered by 
Analysis
Iridex (IRIX) Non Operating Interest Expenses (2012 - 2013) Analysis & Trends
Iridex has reported Non Operating Interest Expenses for 2 years, with the latest figure at $171000.0 in Q4 2013.
- On a quarterly basis, Non Operating Interest Expenses rose 850.0% year-over-year to $171000.0 in Q4 2013; TTM through Dec 2013 was $371000.0, a N/A change from a year earlier, with the FY2013 full-year figure at $371000.0, up 76.67% from the prior year.
- Non Operating Interest Expenses was $171000.0 for Q4 2013 at Iridex, up from $85000.0 in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $171000.0 in Q4 2013, with the low at $18000.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 28, 2013 | 171,000.00 |
| Sep 28, 2013 | 85,000.00 |
| Jun 29, 2013 | 97,000.00 |
| Dec 29, 2012 | 18,000.00 |
| Sep 29, 2012 | 117,000.00 |
| Jun 30, 2012 | 48,000.00 |